본문 바로가기
KERD
논문KCI 등재

Prevalence of Drug Resistance-Associated Gene Mutations in Plasmodium vivax in Central China

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Resistance of Plasmodium spp. to anti-malarial drugs is the primary obstacle in the fight against malaria, and molecular markers for the drug resistance have been applied as an adjunct in the surveillance of the resistance. In this study, we investigated the prevalence of mutations in pvmdr1, pvcrt-o, pvdhfr, and pvdhps genes in temperate-zone P. vivax parasites from central China. A total of 26 isolates were selected, including 8 which were previously shown to have a lower susceptibility to chloroquine in vitro. For pvmdr1, pvcrt-o, and pvdhps genes, no resistance-conferring mutations were discovered. However, a highly prevalent (69.2%), single-point mutation (S117N) was found in pvdhfr gene. In addition, tandem repeat polymorphisms existed in pvdhfr and pvdhps genes, which warranted further studies in relation to the parasite resistance to antifolate drugs. The study further suggests that P. vivax populations in central China may still be relatively susceptible to chloroquine and sulfadoxine-pyrimethamine.

Abstract

Resistance of Plasmodium spp. to anti-malarial drugs is the primary obstacle in the fight against malaria, and molecular markers for the drug resistance have been applied as an adjunct in the surveillance of the resistance. In this study, we investigated the prevalence of mutations in pvmdr1, pvcrt-o, pvdhfr, and pvdhps genes in temperate-zone P. vivax parasites from central China. A total of 26 isolates were selected, including 8 which were previously shown to have a lower susceptibility to chloroquine in vitro. For pvmdr1, pvcrt-o, and pvdhps genes, no resistance-conferring mutations were discovered. However, a highly prevalent (69.2%), single-point mutation (S117N) was found in pvdhfr gene. In addition, tandem repeat polymorphisms existed in pvdhfr and pvdhps genes, which warranted further studies in relation to the parasite resistance to antifolate drugs. The study further suggests that P. vivax populations in central China may still be relatively susceptible to chloroquine and sulfadoxine-pyrimethamine.

참고문헌 (34)

  1. Anstey NM, "The pathophysiology of vivax malaria", Trends Parasitol, 25, pp.220~227 (2009)
  2. Mueller I, "Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite", Lancet Infect Dis, 9, pp.555~566 (2009)
  3. Zhou SS, "Malaria situation in the People’s Republic of China in 2006", Chinese J Parasitol Parasit Dis, 25, pp.439~441 (2007)
  4. Lu F, "In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China", Am J Trop Med Hyg, 85, pp.197~201 (2011)
  5. Suwanarusk R, "Chloroquine resistant Plasmodium vivax: In vitro characterisation and association with molecular polymorphisms", PLoS One, 2, pp.e1089~ (2007)
  6. Brega S, "Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity", J Infect Dis, 191, pp.272~277 (2005)
  7. Tjitra E, "Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine- sulfadoxine-pyrimethamine in vivax malaria pilot studies: Relationship to Plasmodium vivax dhfr mutations", Antimicrob Agents Chemother, 46, pp.3947~3953 (2002)
  8. de Pécoulas PE, "Sequence variations in the Plasmodium vivax dihydrofolate reductase- thymidylate synthase gene and their relationship with pyrimethamine resistance", Mol Biochem Parasitol, 92, pp.265~273 (1998)
  9. Imwong M, "Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates", Antimicrob Agents Chemother, 45, pp.3122~3127 (2001)
  10. Korsinczky M, "Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site", Antimicrob Agents Chemother, 48, pp.2214~2222 (2004)
  11. Phillips EJ, "Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America", Clin Infect Dis, 23, pp.1171~1173 (1996)
  12. Imwong M, "Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand", Antimicrob Agents Chemother, 49, pp.4393~4395 (2005)
  13. Marfurt J, "Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1", J Infect Dis, 198, pp.409~417 (2008)
  14. Sá JM, "Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Pap-ua, and monkey-adapted strains", Exp Parasitol, 109, pp.256~259 (2005)
  15. Nomura T, "Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria", J Infect Dis, 183, pp.1653~1661 (2001)
  16. Lu F, "Molecular test for vivax malaria with loop-mediated isothermal amplification method in central China", PARASITOLOGY RESEARCH, 110(6), pp.2439~2444 (2012), SPRINGER
  17. Miao M, "Different allele prevalence in the dihydrofolate reductase and dihydropteroate synthase genes in Plasmodium vivax populations from China", Am J Trop Med Hyg, 83, pp.1206~1211 (2010)
  18. Chen JS, "Clinical observation on the in vivo sensitivity of Plasmodium vivax to pyrimethamine in Kaifeng District, Henan Province", Henan J Prev Med, pp.51~56 (1977)
  19. Shen JQ, "Comparison of efficacy between long-term oral administration of pyrimethamine and antimalarial pill 3", Railway Med J, 2, pp.90~91 (1978)
  20. Hastings MD, "Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax", Proc Natl Acad Sci USA, 99, pp.13137~13141 (2002)
  21. Hawkins VN, "Antifolates can have a role in the treatment of Plasmodium vivax", Trends Parasitol, 23, pp.213~222 (2007)
  22. Yang XM, "Clinical research of the sensitivity of Plasmodium vivax to chloroquine", Chinese J Parasitol Parasit Dis, 9, pp.226~227 (1996)
  23. Imwong M, "Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar", Antimicrob Agents Chemother, 52, pp.2657~2659 (2008)
  24. Hastings MD, "Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system", Antimicrob Agents Chemother, 49, pp.733~740 (2005)
  25. Auliff A, "Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs", Am J Trop Med Hyg, 75, pp.617~621 (2006)
  26. Rungsihirunrat K, "Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand", Am J Trop Med Hyg, 76, pp.1057~1065 (2007)
  27. Hastings MD, "Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine", J Infect Dis, 189, pp.744~750 (2004)
  28. Lu F, "Mutations in the Antifolate-Resistance-Associated Genes Dihydrofolate Reductase and Dihydropteroate Synthase in Plasmodium vivax Isolates from Malaria-Endemic Countries", AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 83(3), pp.474~479 (2010), AMER SOC TROP MED & HYGIENE
  29. Brega S, "Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates", Antimicrob Agents Chemother, 48, pp.2581~2587 (2004)
  30. Sibley CH, "Pyrimethamine- sulfadoxine resistance in Plasmodium falciparum: what next?", Trends Parasitol, 17, pp.582~588 (2001)
  31. Menegon M, "Genetic variations of the Plasmodium vivax dihydropteroate synthase gene", Acta Trop, 98, pp.196~199 (2006)
  32. Hawkins VN, "Assessment of the origins and spread of putative resistance-conferring mutations in Plasmodium vivax dihydropteroate synthase", Am J Trop Med Hyg, 81, pp.348~355 (2009)
  33. Lu F, "Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries", ACTA TROPICA, 117(2), pp.69~75 (2011), ELSEVIER SCIENCE BV
  34. Huang F, "Monitoring resistance of Plasmodium vivax: point mutations in dihydrofolate reductase gene in isolates from Central China", Parasit Vectors, 4, pp.80~ (2011)

관련 논문AI추천

Plasmodium vivax Drug Resistance Genes; Pvmdr1 and Pvcrt-o Polymorphisms in Relation to Chloroquine Sensitivity from a Malaria Endemic Area of ThailandJiraporn Kuesap, Kanchana Rungsihirunrat1, Kesara Na Bangchang, Poonuch Muhamad2, Wanna Chaijaroenkul대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2015 · 제53권 제1호Plasmodium vivax dhfr Mutations among Isolates from Malarious Areas of IranAbbas Shahbazi, Jalal Zaman, Mohammad Asgharzadeh대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2011 · 제49권 제2호Genetic Polymorphisms in the pvdhfr, pvmdr1, and pvdhps Genes of Plasmodium vivax in Patients at a Secondary Hospital in South Korea김양리, 김현정, 이재웅, 이혜경대한임상미생물학회 · Annals of Clinical Microbiology2022 · 제25권 제1호Genetic Polymorphisms in Plasmodium vivax Dihydrofolate Reductase and Dihydropteroate Synthase in Isolates from the Philippines, Bangladesh, and NepalEffie Espino, Harald Noedl, Jiraporn Kuesap, Kanchana Rungsihirunrat, Kesara Na-Bangchang, Pimwan Thongdee, Shyam Prakash Dumre대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2015 · 제53권 제2호Genetic Diversity and Natural Selection in 42 kDa Region of Plasmodium vivax Merozoite Surface Protein-1 from China-Myanmar Endemic BorderErnest Tambo, Jing Su, Jun-Hu Chen, Mingbo Yin, Qiang Fang, Wei Ruan, Xiao-Nong Zhou, Xia Zhou대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2017 · 제55권 제5호Molecular Markers for Sulfadoxine/Pyrimethamine and Chloroquine Resistance in Plasmodium falciparum in ThailandJiraporn Kuesap, Lertluk Kalawong, Natthaya Khumchum, Nutnicha Suphakhonchuwong대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2022 · 제60권 제2호

이 간행물의 다른 논문 (19건)